| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |